Lee Schacter joins Clinipace
This article was originally published in Scrip
Clinipace, a global digital contract research organization (dCRO), has named Dr Lee Schacter executive medical director, oncology. Dr Schacter will provide strategic guidance, program design, and medical oversight to clients conducting oncology development programs. Prior to joining Morrisville, North Carolina-based Clinipace, Dr Schacter was an independent consultant with Phasen Consulting, during which time he was CMO of the Multiple Myeloma Research Foundation, worked with Janssen R&D, and was medical director for marketed oncology products at AstraZeneca.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.